Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
· 1 hour

Understanding lipoprotein(a) in cardiovascular disease

Wed, Oct 27, 2021 · 4:30 PM · Stockholm
About This Webinar

Epidemiological and mendelian randomization studies have demonstrated lipoprotein(a) to be an independent risk factor for myocardial infarction and stroke. Lipoprotein(a) consists of a specific apolipoprotein(a) that is highly heritable and bound to LDL-C particles. Recent research has increased the understanding of Lipoprotein(a) in disease and new therapies are emerging.
In this webinar speakers will review the current knowledge on lipoprotein(a) from human genetics to atherogenic mechanisms and emerging drug treatment targeting lipoprotein (a).

  • Introduction of topic. Stefano Romeo
  • Potential mechanisms for the atherogenic and thrombotic effect of Lp(a). Alexandros Tselepis
  • From epidemiology to human genetic studies, to define the risk of Lp(a) related CVD disease. Pia Rörbaek-Kamstrup
  • Family screening and drugs targeting Lp(a) for CVD prevention. Massimiliano Ruscica
  • Q&A
Who can view: Everyone
Webinar Price: Free
Featured Presenters
Webinar hosting presenter
MD PhD, Head of Department at the Department of Clinical Biochemistry, Copenhagen University Hospital – Herlev and Gentofte, Denmark
Webinar hosting presenter
Associate professor of General Pathology at Università degli Studi di Milano, Milan, Italy
Attended (248) View all
  • 1635147960-9513ba1818138e8f
  • 1590567232-1a011e675dbc1511
  • S
  • 1635335888-4997e2019ebdcbcd
  • A
  • 1623863130-018963812103181a
  • J
  • C
  • E
  • R
  • I
  • U
  • S
  • L
  • T
  • D
  • G